Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (173)

91

Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells

enthalten in: Journal of inorganic biochemistry | 2020

von Pavlović, M. | Tadić, A. | Gligorijević, N. | +7

92

Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier

enthalten in: The breast journal | 2020

von Desai, N. | Tung, N.

93

Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service

enthalten in: Clinical therapeutics | 2020

von Armeni, P. | Borsoi, L. | Fornaro, G. | +3

94

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy

enthalten in: Breast cancer research and treatment | 2020

von Kawachi, A. | Yamashita, S. | Okochi-Takada, E. | +9

95

Similar response rates and survival with PARP inhibitors for patients with solid tumors harboring somatic versus Germline BRCA mutations : a Meta-analysis and systematic review

enthalten in: BMC cancer | 2020

von Mohyuddin, G. | Aziz, M. | Britt, A. | +6

96

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Waks, A. | Cohen, O. | Kochupurakkal, B. | +22

97

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer : A Network Meta-Analysis

enthalten in: International journal of molecular sciences | 2020

von Bartoletti, M. | Pelizzari, G. | Gerratana, L. | +8

98

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer : a meta-analysis of nine randomized controlled trials

enthalten in: Bioscience reports | 2020

von Shao, F. | Liu, J. | Duan, Y. | +4

99

Functional characterization of 84 PALB2 variants of uncertain significance

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2020

von Wiltshire, T. | Ducy, M. | Foo, T. | +11

CommentIn: Trends Cancer. 2020 Apr;6(4):263-265. - PMID 32209438

100

Allele-specific expression mediates primary resistance to poly (ADP-ribose) polymerase inhibitor therapy in a case of BRCA1/2 double-germline mutant gastric cancer

enthalten in: The Journal of international medical research | 2020

von Wen, L. | Li, X. | Shi, J. | +4